Menus Subscribe Search
science-patient

(PHOTO: EVERETT COLLECTION/SHUTTERSTOCK)

Selling Your Body to Science

• September 03, 2013 • 10:00 AM

(PHOTO: EVERETT COLLECTION/SHUTTERSTOCK)

Medical research depends on human subjects, but should we pay people to be our guinea pigs?

In the back halls of any academic medical center, you’ll find notice boards covered with an assortment of flyers offering money to those willing to participate in medical studies. As a cash-strapped graduate student, I would scan these notices, looking for studies that offered a few hundred dollars in exchange for doing something that didn’t sound too unbearable. I wanted to supplement my meager graduate school stipend, and I had a few resources I could exchange for cash: my blood, my tissues, my immune system, and my tolerance for pain.

The ethics of paying people to volunteer as medical research subjects have been a source of controversy for decades. The primary concern is that money often warps people’s judgment when it comes to assessing risk. Bioethicists worry that a cash offer is an “undue inducement” that will cause low-income people to ignore the risks of a study and compromise their ability to give fully-informed consent. While researchers and institutional ethics committees may see these payments as a benefit that justifies riskier studies.

People who consent to participate in unspecified future studies can’t possibly know in advance what risks they’re exposing themselves to.

Despite bioethicists debating whether and how much human subjects should be paid, academic medical centers and pharmaceutical companies have generally forged ahead and done whatever’s been needed to recruit enough participants for their studies. The results have sometimes been ugly, like when pharmaceutical company Eli Lilly paid homeless alcoholics to participate in safety testing of new drugs.

In a 2011 paper, California bioethicists Ari VanderWalde and Seth Kurzban reviewed the contentious ethical history of paying human subjects and took stock of where things stand now. They argued that the lack of consensus among bioethicists has resulted in an ad hoc, patchwork system that leaves too much up to the individual researchers, who may have good intentions but are “likely to subconsciously exploit, coerce, and put subject health at risk.”

They concluded that, despite disagreement among bioethicists, research institutions are not going to stop using money as a recruitment tool any time soon, and there seems to be no shortage of people willing to sell their bodies to science—human subjects even have their own jobzine, Guinea Pig Zero. The main task now is to work out the ethical framework that should guide these payments, so that subjects are compensated fairly for their efforts, and so that financial incentives don’t hinder their ability to make an informed assessment of the study risks.

UNFORTUNATELY, THE RECENT EXPLOSION in the number of human genetic studies means that an informed risk assessment may no longer be possible. Driven by technological advances in DNA analysis, human genetic studies generate an insatiable demand for human subjects, which has led to a rise in so-called biobanks, which store hundreds of thousands of tissue and genetic samples that can be used in future research. For statistical reasons, human genetic studies often require a very large number of subjects, which means it’s too expensive and time consuming to recruit subjects from scratch for every study. Instead, researchers share samples and data through biobanks and databases like the National Institutes of Health’s database of Genotypes and Phenotypes.

Human subjects are now frequently asked to consent not just to the procedures and risks of a single study, but also to broadly consent to the use of their samples in completely unrelated future studies by different research teams. This kind of broad consent is a new beast on the ethical landscape: people who consent to participate in unspecified future studies can’t possibly know in advance what risks they’re exposing themselves to.

The risks of these future studies obviously aren’t the kind of physical risk that, say, a drug trial involves, but they can still be serious. One very extensive genetic study, the Personal Genomes Project, lists what your genetic data could expose you to: “Anyone with sufficient knowledge” could take that data and “infer paternity or other features of the participant’s genealogy,” “claim relatedness to criminals or incriminate relatives,” or even “make synthetic DNA corresponding to the participant and plant it at a crime scene.”

So what ethical principles should guide payments to human research subjects whose samples might be biobanked, freely shared among researchers, and used in future genetic studies? It’s an issue that has hardly been addressed yet, perhaps because, as some researchers have remarked, “the empirical facts of the genomic science change too fast for the reflections of ethics to keep pace with.” But we have an acute need to set up a consistent ethical framework that can help researchers and institutional ethics committees resolve the tension between the need to share scientific resources and the responsibility to protect the people who put themselves at risk for medical research. If bioethicists and funding agencies don’t get ahead on this issue, individual researchers and institutions will resolve it in their own way, establishing practices that will be hard to change later. Without a uniform framework to guide how we use money as a recruiting tool, we’ve experienced some major ethical lapses in drug trials and traditional medical studies. With genetic studies, we’re at risk for ethical lapses on an even grander scale.

Michael White
Michael White is a systems biologist at the Department of Genetics and the Center for Genome Sciences and Systems Biology at the Washington University School of Medicine in St. Louis, where he studies how DNA encodes information for gene regulation. He co-founded the online science pub The Finch and Pea. Follow him on Twitter @genologos.

More From Michael White

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

July 23 • 2:00 PM

We Need to Start Tracking Patient Harm and Medical Mistakes Now

Top patient-safety experts call on Congress to step in and, among other steps, give the Centers for Disease Control and Prevention wider responsibility for measuring medical mistakes.


July 23 • 12:19 PM

How a CEO’s Fiery Battle Speeches Can Shape Ethical Behavior

CEO war speech might inspire ethical decisions internally and unethical ones among competing companies.


July 23 • 12:00 PM

Why Do We Love the ‘Kim Kardashian: Hollywood’ Game?

It’s easy enough to turn yourself into a virtual celebrity, complete with fame and mansions—but it will likely cost you.


July 23 • 11:49 AM

Modern Technology Still Doesn’t Protect Americans From Deadly Landslides

No landslide monitoring or warning systems are being used to protect vulnerable communities.


July 23 • 10:00 AM

Outing the Death-Drug Distributors

Calling all hackers: It’s time to go Assange on capital punishment.


July 23 • 8:00 AM

The Surprising Appeal of Products That Require Effort to Use

New research finds they enable consumers to re-establish a feeling that they’re in control of their lives.



July 23 • 6:00 AM

How the Other Half Lifts: What Your Workout Says About Your Social Class

Why can’t triathletes and weightlifters get along?


July 23 • 5:02 AM

Battle of the Public Intellectuals: Edward Glaeser vs. Richard Florida

On gentrification and housing costs.


July 23 • 4:00 AM

Our Fear of Immigrants

Why did a group of fourth graders rally in support of an undocumented classmate while the citizens of Murrieta, California, tried to stop immigrant children from entering their town?


July 22 • 4:00 PM

Can Meditation Really Slow Aging?

Is there real science in the spiritualism of meditation? Jo Marchant meets a Nobel Prize-winner who thinks so.



July 22 • 2:00 PM

The Alabama Judge Who Refuses to Let Desegregation Orders Go Ignored

A federal judge in Alabama says a local school board has failed to meet legal mandate to integrate.


July 22 • 12:00 PM

On the Destinations of Species

It’s almost always easier to cross international borders if you’re something other than human.


July 22 • 10:51 AM

The Link Between Carbs, Gut Microbes, and Colon Cancer

Reduced carb intake among mice protected them from colon cancer.


July 22 • 10:47 AM

Irrational Choice Theory: The LeBron James Migration From Miami to Cleveland

Return migrants to Cleveland have been coming home in large numbers for quite some time. It makes perfect sense.


July 22 • 9:32 AM

This Time, Scalia Was Right

President Obama’s recess appointments were wrong and, worse, dangerous.


July 22 • 8:00 AM

On Vegas Strip, Blackjack Rule Change Is Sleight of Hand

Casino operators are changing blackjack payouts to give the house an even greater advantage. Is this a sign that Vegas is on its way back from the recession, or that the Strip’s biggest players are trying to squeeze some more cash out of visitors before the well runs dry?


July 22 • 6:00 AM

Label Me Confused

How the words on a bag of food create more questions than answers.


July 22 • 5:07 AM

Doubly Victimized: The Shocking Prevalence of Violence Against Homeless Women

An especially vulnerable population is surveyed by researchers.


July 22 • 4:00 AM

New Evidence That Blacks Are Aging Faster Than Whites

A large study finds American blacks are, biologically, three years older than their white chronological counterparts.



July 21 • 4:00 PM

Do You Have to Learn How to Get High?

All drugs are socially constructed.


July 21 • 2:14 PM

The New Weapon Against Disease-Spreading Insects Is Big Data

Computer models that pinpoint the likely locations of mosquitoes and tsetse flies are helping officials target vector control efforts.


July 21 • 2:00 PM

Why Are Obstetricians Among the Top Billers for Group Psychotherapy in Illinois?

Illinois leads the country in group psychotherapy sessions in Medicare, and some top billers aren’t mental health specialists. The state’s Medicaid program has cracked down, but federal officials have not.


Follow us


Subscribe Now

How a CEO’s Fiery Battle Speeches Can Shape Ethical Behavior

CEO war speech might inspire ethical decisions internally and unethical ones among competing companies.

Modern Technology Still Doesn’t Protect Americans From Deadly Landslides

No landslide monitoring or warning systems are being used to protect vulnerable communities.

The Link Between Carbs, Gut Microbes, and Colon Cancer

Reduced carb intake among mice protected them from colon cancer.

The New Weapon Against Disease-Spreading Insects Is Big Data

Computer models that pinpoint the likely locations of mosquitoes and tsetse flies are helping officials target vector control efforts.

People Are Clueless About Placebos

Doctors know that sometimes the best medicine is no medicine at all. But how do patients feel about getting duped into recovery?

The Big One

Today, the United States produces less than two percent of the clothing purchased by Americans. In 1990, it produced nearly 50 percent. July/August 2014

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.